Trial Profile
A Randomized, Active-control, Double-blind, Double-dummy Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2023
Price :
$35
*
At a glance
- Drugs Tafenoquine (Primary) ; Chloroquine; Primaquine
- Indications Vivax malaria
- Focus Therapeutic Use
- 24 Jan 2018 Status changed from completed to discontinued.
- 27 Aug 2014 New trial record